|
Originally published In Press as doi:10.1074/jbc.M705869200 on July 30, 2007
J. Biol. Chem., Vol. 282, Issue 39, 28549-28556, September 28, 2007
Tumor Necrosis Factor Receptor-1 Can Function through a G q/11- -Arrestin-1 Signaling Complex*
Yuji Kawamata1,
Takeshi Imamura1,
Jennie L. Babendure,
Juu-Chin Lu,
Takeshi Yoshizaki, and
Jerrold M. Olefsky2
From the
Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, California 92093-0673
Tumor necrosis factor- (TNF ) is a proinflammatory cytokine secreted from macrophages and adipocytes. It is well known that chronic TNF exposure can lead to insulin resistance both in vitro and in vivo and that elevated blood levels of TNF are observed in obese and/or diabetic individuals. TNF has many acute biologic effects, mediated by a complex intracellular signaling pathway. In these studies we have identified new G-protein signaling components to this pathway in 3T3-L1 adipocytes. We found that -arrestin-1 is associated with TRAF2 (TNF receptor-associated factor 2), an adaptor protein of TNF receptors, and that TNF acutely stimulates tyrosine phosphorylation of G q/11 with an increase in G q/11 activity. Small interfering RNA-mediated knockdown of -arrestin-1 inhibits TNF -induced tyrosine phosphorylation of G q/11 by interruption of Src kinase activation. TNF stimulates lipolysis in 3T3-L1 adipocytes, and -arrestin-1 knockdown blocks the effects of TNF to stimulate ERK activation and glycerol release. TNF also led to activation of JNK with increased expression of the proinflammatory gene, monocyte chemoattractant protein-1 and matrix metalloproteinase 3, and -arrestin-1 knockdown inhibited both of these effects. Taken together these results reveal novel elements of TNF action; 1) the trimeric G-protein component G q/11 and the adapter protein -arrestin-1 can function as signaling molecules in the TNF action cascade; 2) -arrestin-1 can couple TNF stimulation to ERK activation and lipolysis; 3) -arrestin-1 and G q/11 can mediate TNF -induced phosphatidylinositol 3-kinase activation and inflammatory gene expression.
Received for publication, July 17, 2007
* This work was supported by National Institutes of Health Research Grant DK 33651, University of California Discovery Program Project bio03-10383 (BioStar), and United States and Israel Binational Scientific Foundation Grant 2003238. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed: University of California, San Diego, Dept. of Medicine (0673), 9500 Gilman Dr., La Jolla, CA 92093. Tel.: 858-534-6651; Fax: 858-534-6653; E-mail: jolefsky{at}ucsd.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Lymperopoulos, G. Rengo, C. Zincarelli, J. Kim, S. Soltys, and W. J. Koch
An adrenal {beta}-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo
PNAS,
April 7, 2009;
106(14):
5825 - 5830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sonoda, T. Imamura, T. Yoshizaki, J. L. Babendure, J.-C. Lu, and J. M. Olefsky
{beta}-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic {beta} cells
PNAS,
May 6, 2008;
105(18):
6614 - 6619.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|